セッション詳細
[WS(O)29]Cell therapy, vaccine, and new therapeutic modality
2024年12月5日(木) 12:50 〜 14:05
Room H
Organizers: Hiroaki Ikeda (Nagasaki University), Tsukasa Nabekura (Aichi Cancer Center)
[WS29-01-O/P]Development of new adoptive T cell therapy that overcomes tumor heterogeneity with escape variant tumor clones.
○Kiyoshi Yasui1, Daisuke Ehara1,2, Mitsuhiro Yoneda1, Situo Deng1, Sachiko Okamoto3, Yasunori Amaishi3, Daisuke Muraoka4, Naohisa Ogo5, Akira Asai5, Hiroyuki Murota2, Hiroaki Ikeda1 (1.Nagasaki Univ. Grad. Sch. of Biomed. Sci., Dept. of Oncology., 2.Nagasaki Univ. Grad. Sch. of Biomed. Sci., Dept. of Dermatology., 3.Tech. Development Ctr, Takara Bio Inc., 4.Aichi Cancer Ctr. Res. Inst., Div. of Translational Oncoimmunology., 5.Ctr. for Drug Discovery, Grad. Div. Pharm., Univ. of Shizuoka.)
[WS29-03-O/P]The relationship between receptor shedding andTrogocytosis
○Atsutaka Minagawa, Shin Kaneko (Kyoto University)
[WS29-04-O/P]Efficient production of CAR-NK cells with a potent antitumor effect using leukocyte progenitor cells
○Jia Han, Tsukasa Shigehiro, Shogo Tanimori, Hiroyuki Kadota, Karin Noma, Tomokatsu Ikawa (Tokyo University of Science, Research Institute for Biomedical Science)
[WS29-06-O/P]Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and CAR-T cells
○Ryohei Matsushima1,2, Ei Wakamatsu1, Hiroaki Machiyama1, Wataru Nishi2, Yosuke Yoshida1,3, Tetsushi Nishikawa1,4, Hiroko Toyota1, Masae Furuhata1, Hitoshi Nishijima1, Arata Takeuchi1, Makoto Suzuki2, Tadashi Yokosuka1 (1.Tokyo Medical University department of Immunology, 2.Kumamoto University department of Thoracic Surgery, 3.Tokyo Medical University Department of Nephrology, 4.Tokyo Medical University Department of Dermatology)
[WS29-08-O/P]Breast cancer specific antigen recognition by TIL-derived MR1-restricted TCRs
○Abdul Hayee1, Eiji Kobayashi1, Hiroshi Hamana2, Chihiro Motozono3, Satoshi Yamaguchi1, Ha Thi Viet My1, Tatsuhiko Ozawa1, Hiroyuki Kishi1 (1.Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan, 2.Shinobi Therapeutics Co., Ltd., Kyoto, Japan, 3.Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan)
[WS29-11-O/P]Withdrawn
[WS29-26-O/P]In vivo Generation of Designer antigen-presenting cells using mRNA for Cancer Immunotherapy
○Tomoyoshi Yamano, Toan Van Le, Shota Imai, Iriya Fujitsuka, RIkinari Hanayama (Department of Immunology, Kanazawa University)
[WS29-28-O/P]Antitumor immunity via harnessing nano-sized membrane vesicles
○Mirei Kataoka1, Yusuke Ito1, Seiichi Ohta2, Yuki Kagoya1 (1.Keio University, 2.The University of Tokyo)